Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

M&A

Set Alert for MandA

Animal Pharm Awards presents accolades to serial winners and new names

Zoetis, Merck Animal Health and Biogénesis Bagó have all won Animal Pharm Awards in 2018 – adding to their accolades from previous years.

Biogenesis Bago Kindred Biosciences

Candioli to expand global reach of new UK acquisition

Italian companion animal health company Candioli aims to grow the European horizons of its latest acquisition.

Deals M&A

Re-scheduled Animal Pharm investment webinar to air next week

Animal Pharm is teaming up with Kisaco Research to host a webinar dedicated to investment in the animal health industry. 

Investments Deals

Heska represents 'obvious fit' for Mars or Covetrus, claims Canaccord

US financial services firm Canaccord Genuity believes Heska is an ideal acquisition target for animal health companies.

Heska M&A

Grey Wolf gains acquires Veterinary Healthcare Solutions

Grey Wolf Animal Health has purchased fellow Canadian company Veterinary Healthcare Solutions (VHS).

Canada M&A

Neogen expands genomics portfolio with Canadian facility acquisition

Neogen has acquired the assets of the Delta Genomics Centre – a animal genomics laboratory in Edmonton, Canada

Canada M&A

Review 2018: Smart M&A money is put on diagnostics and digital tech

In 2018, the stand-out M&A deals targeted diagnostics, digital technologies and nutrition. While Zoetis and Merck Animal Health made multi-billion-dollar deals, some of the sector's smaller purchases also hinted towards important trends. Animal Pharm editor Joseph Harvey looks back at where the money was spent.

M&A Abaxis

Vets Plus builds presence in Wisconsin with Merrick's acquisition

US animal health firm Vets Plus has purchased fellow Wisconsin-based company Merrick's – a manufacturer of boluses, tablets, powders and electrolytes for the livestock sector.

M&A

MSD secures first fully-owned Chinese vaccine facility with Zhejiang acquisition

MSD Animal Health's has purchased Zhejiang ZhengliAntoo Biotech – a privately owned veterinary vaccine specialist based in China – for an undisclosed fee.

Merck MSD Animal Health China

Schein, Vets First Choice spin-out to become Covetrus in Q1; leadership team revealed

The new standalone public entity that will be formed by the spin-off of Henry Schein Animal Health and its merger with Vets First Choice will be called Covetrus.

Equipment & Technology M&A

Private equity supports management buyout of UK vet diagnostics firm

UK-based Hallmarq Veterinary Imaging has executed a management buyout, which was supported by mid-market private equity firm August Equity.

M&A Equipment & Technology

Dechra finalizes Vencofarma acquisition, adds non-executive director

UK firm Dechra Pharmaceuticals has completed its acquisition of Laboratorios Vencofarma do Brasil (Venco) for R$185 million ($49.7 million).

Dechra Pharmaceuticals M&A
Advertisement
UsernamePublicRestriction

Register